FORMULATION CONCERNS OF PROTEIN DRUGS

被引：46
作者：
CHEN, T
机构：
[1] Pharmaceutics Research and Development Bristol-Myers Squibb, Pharmaceutical Research Institute, Syracuse, NY
来源：
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 1992年 / 18卷 / 11-12期
关键词：
D O I：
10.3109/03639049209046331
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：1311 / 1354
页数：44
相关论文
共 165 条
[1]   PROTEIN ADSORPTION TO POLYMER PARTICLES - ROLE OF SURFACE-PROPERTIES [J].
ABSOLOM, DR ;
ZINGG, W ;
NEUMANN, AW .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1987, 21 (02) :161-171
[2]   THE MECHANISM OF IRREVERSIBLE ENZYME INACTIVATION AT 100-DEGREES-C [J].
AHERN, TJ ;
KLIBANOV, AM .
SCIENCE, 1985, 228 (4705) :1280-1284
[3]   CHANGES IN CHROMATIN STRUCTURE DURING THE AGING OF CELL-CULTURES AS REVEALED BY DIFFERENTIAL SCANNING CALORIMETRY [J].
ALMAGOR, M ;
COLE, RD .
BIOCHEMISTRY, 1989, 28 (13) :5688-5693
[4]   PH-INDUCED DENATURATION OF PROTEINS - A SINGLE SALT BRIDGE CONTRIBUTES 3-5 KCAL MOL TO THE FREE-ENERGY OF FOLDING OF T4-LYSOZYME [J].
ANDERSON, DE ;
BECKTEL, WJ ;
DAHLQUIST, FW .
BIOCHEMISTRY, 1990, 29 (09) :2403-2408
[5]  
ANGELL CA, 1979, COMPR TREAT, V7, P1
[6]  
[Anonymous], 1989, PROTEIN STRUCTURE PR
[7]   WHY PREFERENTIAL HYDRATION DOES NOT ALWAYS STABILIZE THE NATIVE STRUCTURE OF GLOBULAR-PROTEINS [J].
ARAKAWA, T ;
BHAT, R ;
TIMASHEFF, SN .
BIOCHEMISTRY, 1990, 29 (07) :1924-1931
[8]  
ARAKAWA T, 1985, METHOD ENZYMOL, V114, P49
[9]   PROTEIN-SOLVENT INTERACTIONS IN PHARMACEUTICAL FORMULATIONS [J].
ARAKAWA, T ;
KITA, Y ;
CARPENTER, JF .
PHARMACEUTICAL RESEARCH, 1991, 8 (03) :285-291
[10]   HOW DOES PROTEIN FOLDING GET STARTED [J].
BALDWIN, RL .
TRENDS IN BIOCHEMICAL SCIENCES, 1989, 14 (07) :291-294
12345678910